SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-002210
Filing Date
2024-01-04
Accepted
2024-01-04 19:13:21
Documents
2
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2171
2 EX-24.1 howl-ex24_1.htm EX-24.1 12293
  Complete submission text file 0000950170-24-002210.txt   15941
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O WEREWOLF THERAPEUTICS, INC. 200 TALCOTT AVE., 2ND FLOOR WATERTOWN MA 02472
Business Address
Atkins Michael B. (Reporting) CIK: 0002004793 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 24513974